Organization: Centres of Excellence for Commercialization and Research

GreenCentre Canada licenses pharma catalyst

GreenCentre Canada (GCC) has licensed a chemical process developed at the Univ of Alberta that addresses one of the key research priorities of the pharmaceutical industry. The process — developed by U of A chemist Dr Dennis Hall — uses a novel, heavy-metal-free catalyst to create amide bonds at room temperature without creating toxic by-products.…

Alberta and Li Ka Shing fund new virology institute

Hong Kong industrialist Li Ka Shing is contributing $25 million to establish the Li Ka Shing Institute of Virology at the Univ of Alberta, augmented by $52.5 million from the provincial government and Alberta Innovates. The institute will focus on developing and commercializing new drugs, vaccines and diagnostic tests to reduce the impact of viral…

MaRS Innovation to commercialize two technologies

MaRS Innovation has announced its first two medical technologies for commercialization. MaRS Innovation — funded through the Centres of Excellence for Commercialization and Research program (R$, October 7/08) — is collaborating with the Samuel Lunenfeld Research Institute (SLRI) to commercialize an umbilical cord stem cell technology to initially treat diabetes and possible cardiovascular disease and…